LYNN CHUONG: Open Payments
NPI 1386359511 · LIVE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,055 in 166 payments from 20 companies in 2025. Trend: 2023 $2,220 · 2024 $3,003 · 2025 $3,055
Food & beverage: $2,970Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $624 |
| Madrigal Pharmaceuticals | 18 | $396 |
| Janssen Biotech, Inc. | 22 | $395 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $295 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $263 |
| Ardelyx, Inc. | 9 | $178 |
| Ipsen Biopharmaceuticals, Inc | 15 | $168 |
| Celltrion USA Inc. | 7 | $153 |
| Lilly USA, LLC | 6 | $118 |
| Gilead Sciences, Inc. | 5 | $105 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, XIFAXAN, IBSRELA, IQIRVO, VEGZELMA, ENTYVIO.
Industry payments across TX — which companies pay providers there.
